← All stocks

Viking Therapeutics, Inc.

VKTX No buying or selling

CIK 0001607678 #1525 in the set updated 18 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

10 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Lian Brian

President & CEO

—

2,572,441

$86.09M

+8.7%

Mancini Marianna

Chief Operating Officer

—

422,760

$14.15M

+13.2%

ZANTE GREG

Chief Financial Officer

—

212,204

$7.10M

+6.2%

FOEHR MATTHEW W

Director

—

135,186

$4.52M

+21.5%

MACARTNEY LAWSON

Director

—

51,115

$1.71M

+6.6%

Rowland Charles A Jr

Director

—

33,150

$1.11M

+10.5%

SINGLETON J MATTHEW

Director

—

12,650

$423.33K

+33.2%

Kelly-Gemmell Dorothy Elizabeth

Director

—

6,333

$211.94K

—

Aubuchon Neil William

Chief Commercial Officer

—

4,475

$149.76K

—

Rouan Sarah Kathryn

Director

—

4,390

$146.91K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 15 Nov 2016